Pfizer CEO Albert Bourla on Saturday said people getting COVID-19 booster shots every four to five months is “not a good scenario” and argued that an annual vaccine would be
Three studies released Friday offered more evidence that COVID-19 vaccines are standing up to the omicron variant, at least among people who received booster shots. They are the first large
New research from a trial involving 52 Canadian hospitals indicates use of the antiviral Remdesivir could reduce the need for medical ventilation by nearly 50% in patients hospitalised with Covid-19,
The eyes may offer a “window into the soul,” as poets say, but they also have a lot to say about your health. Dry eyes can be a sign of
One in ten people may still be infectious for SARS-CoV-2, the virus that causes COVID-19, after the 10 day quarantine period, according to a study. The research, published recently in
Researchers have identified a specific gene variant that protects against severe COVID-19 infection. An international team led by researchers at Karolinska Institutet in Sweden pinpointed the variant by studying people
Russia’s Sputnik V anti-coronavirus vaccine has proven a good level of efficacy against the omicron variant of the novel coronavirus, Russian Direct Investment Fund (RDIF) head Kirill Dmitriev was quoted
Japanese researchers at Tokyo’s Keio University on Friday said it has conducted the world’s first clinical test involving the transplant of cells developed from iPS (induced pluripotent stem) cells to
Natural defences against a common cold could offer some protection against Covid-19, too, research suggests. The small-scale study, published in Nature Communications, involved 52 individuals who lived with someone who
Pfizer expects a Covid-19 vaccine targeting the Omicron variant to be ready in March, the company’s head said Monday. Pfizer Chief Executive Officer Albert Bourla told CNBC that Pfizer is